BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12851681)

  • 1. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
    Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
    Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
    Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
    Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.
    Zang C; Wächter M; Liu H; Posch MG; Fenner MH; Stadelmann C; von Deimling A; Possinger K; Black KL; Koeffler HP; Elstner E
    J Neurooncol; 2003 Nov; 65(2):107-18. PubMed ID: 14686729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
    Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
    Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
    Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
    Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
    Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
    Kanbe E; Abe A; Towatari M; Kawabe T; Saito H; Emi N
    Exp Hematol; 2003 Apr; 31(4):300-8. PubMed ID: 12691917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
    Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.
    Sato H; Ishihara S; Kawashima K; Moriyama N; Suetsugu H; Kazumori H; Okuyama T; Rumi MA; Fukuda R; Nagasue N; Kinoshita Y
    Br J Cancer; 2000 Nov; 83(10):1394-400. PubMed ID: 11044367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
    Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.